• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫腺肌病的保留子宫手术治疗。

Uterus-sparing operative treatment for adenomyosis.

机构信息

1st Department of Obstetrics and Gynecology, Aristotle University of Thessaloniki, Thessaloniki, Greece.

1st Department of Obstetrics and Gynecology, Aristotle University of Thessaloniki, Thessaloniki, Greece.

出版信息

Fertil Steril. 2014 Feb;101(2):472-87. doi: 10.1016/j.fertnstert.2013.10.025. Epub 2013 Nov 26.

DOI:10.1016/j.fertnstert.2013.10.025
PMID:24289992
Abstract

OBJECTIVE

To review systematically the literature on uterus-sparing surgical treatment options for adenomyosis.

DESIGN

Systematic literature review.

SETTING

Tertiary academic center.

PATIENT(S): Women with histologically proven adenomyosis treated with uterus-sparing surgical techniques.

INTERVENTION(S): Conservative uterine-sparing surgery for adenomyosis classified as (1) complete excision of adenomyosis, (2) cytoreductive surgery or incomplete removal of the lesion, or (3) nonexcisional techniques, with studies selected if women with adenomyosis were treated surgically without performing hysterectomy.

MAIN OUTCOME MEASURE(S): The cure rate after interventional strategies, the rate of symptom (dysmenorrhea and menorrhagia) control, and pregnancy rate in each group of intervention.

RESULT(S): A quality assessment tool was used to assess the scientific value of each study. In total, 64 studies dealing with 1,049 patients were identified. After complete excision, the dysmenorrhea reduction, menorrhagia control, and pregnancy rate were 82.0%, 68.8%, and 60.5%, respectively. After partial excision, the dysmenorrhea reduction, menorrhagia control, and pregnancy rate were 81.8%, 50.0%, and 46.9%, respectively.

CONCLUSION(S): Uterine-sparing operative treatment of adenomyosis and its variants appear to be feasible and efficacious. Well-designed, comparative studies are urgently needed to answer the multiple questions arising from this intriguing intervention.

摘要

目的

系统回顾关于子宫腺肌病保留子宫的手术治疗选择的文献。

设计

系统文献回顾。

设置

三级学术中心。

患者

经组织学证实的子宫腺肌病患者,采用保留子宫的手术技术治疗。

干预措施

保守性子宫腺肌病保留子宫手术分为(1)完全切除子宫腺肌病,(2)减瘤手术或不完全切除病变,或(3)非切除术技术,如果患有子宫腺肌病的女性在不进行子宫切除术的情况下接受手术治疗,则选择研究。

主要观察指标

干预策略后的治愈率、症状(痛经和月经过多)控制率以及每组干预措施的妊娠率。

结果

使用质量评估工具评估了每项研究的科学价值。共确定了 64 项涉及 1049 名患者的研究。完全切除后,痛经缓解率、月经过多控制率和妊娠率分别为 82.0%、68.8%和 60.5%。部分切除后,痛经缓解率、月经过多控制率和妊娠率分别为 81.8%、50.0%和 46.9%。

结论

子宫腺肌病及其变体的保留子宫手术治疗似乎是可行和有效的。迫切需要设计良好的比较研究来回答这一引人入胜的干预措施所带来的多个问题。

相似文献

1
Uterus-sparing operative treatment for adenomyosis.子宫腺肌病的保留子宫手术治疗。
Fertil Steril. 2014 Feb;101(2):472-87. doi: 10.1016/j.fertnstert.2013.10.025. Epub 2013 Nov 26.
2
Pregnancy Outcomes after Uterus-sparing Operative Treatment for Adenomyosis: A Systematic Review and Meta-analysis.子宫腺肌病保留子宫手术治疗后的妊娠结局:系统评价和荟萃分析。
J Minim Invasive Gynecol. 2023 Jul;30(7):543-554. doi: 10.1016/j.jmig.2023.03.015. Epub 2023 Mar 25.
3
Fertility-sparing surgical interventions for low-risk, non-metastatic gestational trophoblastic neoplasia.低危、非转移性妊娠滋养细胞肿瘤的保留生育功能的手术干预。
Cochrane Database Syst Rev. 2024 Sep 23;9(9):CD014755. doi: 10.1002/14651858.CD014755.pub2.
4
Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.对于月经过多进行子宫内膜破坏术前的子宫内膜减薄剂。
Cochrane Database Syst Rev. 2002(3):CD001124. doi: 10.1002/14651858.CD001124.
5
Adenomyosis and subfertility: a systematic review of prevalence, diagnosis, treatment and fertility outcomes.腺肌病与不孕:患病率、诊断、治疗和生育结局的系统评价。
Hum Reprod Update. 2012 Jul;18(4):374-92. doi: 10.1093/humupd/dms006. Epub 2012 Mar 22.
6
Treatment strategies for adenomyosis before and after introducing USgHIFU in Shenzhen.深圳引入超声引导高强度聚焦超声(USgHIFU)前后子宫腺肌病的治疗策略
Int J Hyperthermia. 2025 Dec;42(1):2501244. doi: 10.1080/02656736.2025.2501244. Epub 2025 Jun 16.
7
Efficacy of high-intensity focused ultrasound combined with LNG-IUS for adenomyosis: a systematic review and meta-analysis.高强度聚焦超声联合LNG-IUS 治疗子宫腺肌病的疗效:系统评价和荟萃分析。
Arch Gynecol Obstet. 2023 Aug;308(2):351-362. doi: 10.1007/s00404-022-06720-z. Epub 2022 Aug 10.
8
Baseline anatomical assessment of the uterus and ovaries in infertile women: a systematic review of the evidence on which assessment methods are the safest and most effective in terms of improving fertility outcomes.对不孕女性子宫和卵巢的基础解剖评估:系统回顾评估方法在提高生育结局方面的安全性和有效性的证据。
Hum Reprod Update. 2017 Sep 1;23(5):533-547. doi: 10.1093/humupd/dmx019.
9
The role of hysteroscopy in patients with adenomyosis and infertility: bringing out the submerged.宫腔镜检查在子宫腺肌病和不孕症患者中的作用:揭示隐匿情况。
Fertil Steril. 2025 Jun;123(6):1140-1142. doi: 10.1016/j.fertnstert.2025.02.003. Epub 2025 Feb 7.
10
Does Minimally Invasive Surgery Provide Better Clinical or Radiographic Outcomes Than Open Surgery in the Treatment of Hallux Valgus Deformity? A Systematic Review and Meta-analysis.微创外科治疗拇外翻畸形是否优于开放手术:系统评价和荟萃分析。
Clin Orthop Relat Res. 2023 Jun 1;481(6):1143-1155. doi: 10.1097/CORR.0000000000002471. Epub 2022 Nov 4.

引用本文的文献

1
Adenomyomectomy with preconceptional transabdominal cervicoisthmic cerclage for transvaginal cerclage failure.对于经阴道宫颈环扎失败的情况,采用孕前经腹宫颈峡部环扎术联合子宫腺肌病切除术。
Front Surg. 2025 Jun 13;12:1484120. doi: 10.3389/fsurg.2025.1484120. eCollection 2025.
2
Pedunculated Adenomyoma with Osseous Metaplasia: A Case Report.带蒂腺肌瘤伴骨化生:一例报告
Gynecol Minim Invasive Ther. 2025 May 22;14(2):185-188. doi: 10.4103/gmit.GMIT-D-24-00026. eCollection 2025 Apr-Jun.
3
Role of SMOC2 in adenomyosis: implications for ECM remodeling and EMT pathogenesis.
SMOC2在子宫腺肌病中的作用:对细胞外基质重塑和上皮-间质转化发病机制的影响
BMC Womens Health. 2025 Apr 3;25(1):155. doi: 10.1186/s12905-025-03700-8.
4
Scientific landscape and visualization analysis of the link between adenomyosis and infertility from 2000 to 2024.2000年至2024年子宫腺肌病与不孕症之间联系的科学态势与可视化分析
Front Med (Lausanne). 2025 Feb 19;12:1488866. doi: 10.3389/fmed.2025.1488866. eCollection 2025.
5
Recurrence rates and associated risk factors after conservative surgery for adenomyosis: a retrospective study.保守性手术治疗子宫腺肌病后的复发率及相关危险因素:一项回顾性研究。
BMC Womens Health. 2024 Nov 22;24(1):619. doi: 10.1186/s12905-024-03457-6.
6
Robotic-assisted excision of diffuse adenomyosis.机器人辅助下弥漫性子宫腺肌病切除术
Facts Views Vis Obgyn. 2024 Sep;16(3):365-368. doi: 10.52054/FVVO.16.3.034.
7
Adenomyosis: An Update Concerning Diagnosis, Treatment, and Fertility.子宫腺肌病:关于诊断、治疗及生育能力的最新进展
J Clin Med. 2024 Sep 3;13(17):5224. doi: 10.3390/jcm13175224.
8
The Current Understanding of Molecular Mechanisms in Adenomyosis-Associated Infertility and the Treatment Strategy for Assisted Reproductive Technology.腺肌病相关不孕的分子机制认识现状及辅助生殖技术的治疗策略。
Int J Mol Sci. 2024 Aug 16;25(16):8937. doi: 10.3390/ijms25168937.
9
WeChat assisted electronic symptom measurement for patients with adenomyosis.微信辅助的子宫腺肌病患者电子症状测量。
BMC Med Inform Decis Mak. 2024 Jun 17;24(1):168. doi: 10.1186/s12911-024-02570-8.
10
[Classification of Uterine Adenomyosis: A Pictorial Essay].[子宫腺肌病的分类:图文综述]
J Korean Soc Radiol. 2024 May;85(3):549-565. doi: 10.3348/jksr.2023.0062. Epub 2024 Mar 26.